Return
Brief Report: Accelerating Lung Cancer Management Through Pre-Visit Liquid Biopsy: Results From the LUNG-FAST Pilot Study
E
N
N
D
M
R
J
S
L
DOI:10.1016/j.cllc.2026.06.010.png)
Abstract
En 中文
Timely molecular profiling is critical for treatment selection in non-small cell lung cancer, yet delays in biomarker testing remain common. We evaluated the feasibility and early clinical impact of a nurse-navigator-driven workflow to initiate liquid biopsy prior to the initial oncology visit.
Journal
IF:
3.3
Papers:
2.4K
Citations:
4.5K
